Women told to delay pregnancy as new Brazilian Covid variant feared to be more dangerous

Brazil ’second highest Covid death toll in the world’ says expert

When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.

Health officials in Brazil have urged women not to have children at this present time and wait until after the peak of the pandemic as the virus rages across the country. Brazil is currently being overwhelmed by a second wave of COVID-19 infections and has the second-highest death toll in the world. The COVID-19 variant, known as P1, was first discovered in Manaus and is thought to be the driving factor behind the number of deaths surpassing 350,000.

Raphael Camara, Secretary of Primary Health Care of the Brazilian health ministry, issued the new advice during a press conference on Friday.

Mr Camara warned studies have suggested the new Brazil variant was “more aggressive” in expectant mothers.

He said: “If possible postpone the pregnancy a bit to a better time so that [they] can have a more peaceful pregnancy.”

The Health chief added: “The clinical view of experts shows that the new variant has a more aggressive action on pregnant women.

“Before, severity was linked to the end of the pregnancy, but now they see a more serious evolution in the second trimester and even in the first trimester.”

Brazil has recorded 13.8 million positive cases of COVID-19 and 368,749 coronavirus-related deaths since the start of the pandemic.

The current outbreak in Brazil is increasingly affecting younger people.

Hospital data for March showed more than half of all patients in intensive care were aged 40 or younger.

Hospital beds in major cities, including Sao Paulo, are running at 85 percent capacity.

This week, vaccinations also slowed down in several cities due to a shortage of vaccine supply.

Meanwhile, health chiefs in the UK have said pregnant women should be offered a COVID-19 jab at the same time as the rest of the population based on their age and clinical risk group

The Joint Committee on Vaccination and Immunisation (JCVI) said there were “no specific safety concerns” identified with “any brand of COVID-19 vaccines” in relation to pregnancy.

It said data from the US showed around 90,000 pregnant women had received jabs, mainly the Pfizer-BioNTech and Moderna vaccines, “without any safety concerns being raised”.

As a result, the JCVI said it advises that it is “preferable” for pregnant women in the UK to be offered these two vaccines where available.

It added: “There is no evidence to suggest that other vaccines are unsafe for pregnant women, but more research is needed.”

Professor Wei Shen Lim, COVID-19 chair for JCVI, said: “We encourage pregnant women to discuss the risks and benefits with their clinician – those at increased risk of severe outcomes from COVID-19 are encouraged to promptly take up the offer of vaccination when offered.

DON’T MISS

Prince William and Harry reunited marks Royals ‘coming back together’ [INSIGHT]
Royal Family could ‘grieve privately’ behind masks and hide emotions [ANALYSIS]
Queen sits alone in heartbreaking St George’s Chapel picture [PICTURES]

“There have been no specific safety concerns from any brand of Covid-19 vaccines in relation to pregnancy.

“There are more real-world safety data from the US in relation to the Pfizer-BioNTech and Moderna vaccines in women who are pregnant – therefore, we advise a preference for these to be offered to pregnant women.”

Dr Mary Ramsay, head of immunisation at Public Health England, said: “The available data on the Pfizer-BioNTech and Moderna vaccines provide confidence that they can be offered safely to pregnant women.

“The COVID-19 vaccines continue to save thousands of lives and it is important that we encourage as many people as possible to take up the offer when it is their turn.”

Source: Read Full Article